{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T15:30:09Z","timestamp":1789745409181,"version":"4.0.1"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T00:00:00Z","timestamp":1769040000000},"content-version":"vor","delay-in-days":21,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004606","name":"Chang Gung Medical Foundation","doi-asserted-by":"publisher","award":["CMRPD1P0091"],"award-info":[{"award-number":["CMRPD1P0091"]}],"id":[{"id":"10.13039\/501100004606","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Formosan Medical Association"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.jfma.2026.01.051","type":"journal-article","created":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T21:05:57Z","timestamp":1769202357000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Five-year population-based study of essential thrombocythemia in Taiwan: Epidemiology, treatment patterns, and sex-based disparities"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3511-2390","authenticated-orcid":false,"given":"Alex","family":"Jia-Hong Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5921-5346","authenticated-orcid":false,"given":"Cih-En","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsung-Hsien","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Hao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Cheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Sun","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7492-5570","authenticated-orcid":false,"given":"Lennex","family":"Hsueh-Lin Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuan-Der","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Chi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jfma.2026.01.051_bib1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s11899-025-00752-3","article-title":"Highlights from MPN Asia 2025: advances in molecular pathogenesis and therapeutic strategies in myeloproliferative neoplasms","volume":"20","author":"Bose","year":"2025","journal-title":"Curr Hematol Malignan Rep"},{"issue":"1","key":"10.1016\/j.jfma.2026.01.051_bib2","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1186\/s12913-023-09901-x","article-title":"Impact of the COVID-19 pandemic on population-based cancer screening, a nationwide retrospective study in Taiwan","volume":"23","author":"Su","year":"2023","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.jfma.2026.01.051_bib3","doi-asserted-by":"crossref","DOI":"10.1177\/20406207251359651","article-title":"Real-world characteristics and treatment patterns in essential thrombocythemia: a population-based cross-sectional study in Taiwan between 2020 and 2021","volume":"16","author":"Yu","year":"2025","journal-title":"Ther Adv Hematol"},{"issue":"12","key":"10.1016\/j.jfma.2026.01.051_bib4","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1182\/bloodadvances.2019001407","article-title":"Sex determines the presentation and outcomes in MPN and is related to sex-specific differences in the mutational burden","volume":"4","author":"Karantanos","year":"2020","journal-title":"Blood Adv"},{"issue":"1","key":"10.1016\/j.jfma.2026.01.051_bib5","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3324\/haematol.2016.149559","article-title":"Associations between gender, disease features and symptom burden in patients with myeloproliferative neoplasms: an analysis by the MPN QOL international working group","volume":"102","author":"Geyer","year":"2017","journal-title":"Haematologica"},{"issue":"11","key":"10.1016\/j.jfma.2026.01.051_bib6","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1002\/1097-0142(19861201)58:11<2440::AID-CNCR2820581115>3.0.CO;2-Y","article-title":"Essential thrombocythemias. Clinical evolutionary and biological data","volume":"58","author":"Bellucci","year":"1986","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.jfma.2026.01.051_bib7","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s12185-014-1567-1","article-title":"JAK2V617F mutation status and allele burden in classical Ph-negative myeloproliferative neoplasms in Japan","volume":"99","author":"Edahiro","year":"2014","journal-title":"Int J Hematol"},{"issue":"Suppl 4","key":"10.1016\/j.jfma.2026.01.051_bib8","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/ajh.27665","article-title":"Topics of interest in women with myeloproliferative neoplasms","volume":"100","author":"Szuber","year":"2025","journal-title":"Am J Hematol"},{"issue":"9","key":"10.1016\/j.jfma.2026.01.051_bib9","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1080\/10428194.2021.1901096","article-title":"Myeloproliferative neoplasm questionnaire: assessing patient disease knowledge in the modern digital information era","volume":"62","author":"Pemmaraju","year":"2021","journal-title":"Leuk Lymphoma"},{"issue":"8","key":"10.1016\/j.jfma.2026.01.051_bib10","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1080\/10428194.2020.1749607","article-title":"Healthcare resource utilization in myeloproliferative neoplasms: a population-based study from Ontario, Canada","volume":"61","author":"Bankar","year":"2020","journal-title":"Leuk Lymphoma"},{"issue":"1","key":"10.1016\/j.jfma.2026.01.051_bib11","first-page":"219","article-title":"Cost-utility analysis of ropeginterferon alfa-2b to manage low-risk patients with polycythemia vera as compared to phlebotomy only in the Austrian healthcare system","volume":"104","author":"Walter","year":"2025","journal-title":"Ann Hematol"},{"issue":"1","key":"10.1016\/j.jfma.2026.01.051_bib12","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1080\/03007995.2024.2438996","article-title":"Characteristics, blood counts, treatments, and clinical outcomes of 5871 patients with polycythemia vera treated in US community practices","volume":"41","author":"Lyons","year":"2025","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.jfma.2026.01.051_bib13","doi-asserted-by":"crossref","DOI":"10.1177\/20406207231179331","article-title":"Real-world patient characteristics and treatment patterns of polycythemia vera in Taiwan between 2016 and 2017: a nationwide cross-sectional study","volume":"14","author":"Tsai","year":"2023","journal-title":"Ther Adv Hematol"},{"issue":"17","key":"10.1016\/j.jfma.2026.01.051_bib14","doi-asserted-by":"crossref","first-page":"5171","DOI":"10.1182\/bloodadvances.2022007201","article-title":"Real-world study of children and young adults with myeloproliferative neoplasms: identifying risks and unmet needs","volume":"6","author":"Sobas","year":"2022","journal-title":"Blood Adv"},{"issue":"9","key":"10.1016\/j.jfma.2026.01.051_bib15","doi-asserted-by":"crossref","DOI":"10.57264\/cer-2023-0066","article-title":"Cost-effectiveness of ropeginterferon alfa-2b-njft for the treatment of polycythemia vera","volume":"12","author":"Gerds","year":"2023","journal-title":"J Comp Eff Res"},{"issue":"2","key":"10.1016\/j.jfma.2026.01.051_bib16","doi-asserted-by":"crossref","first-page":"162","DOI":"10.36469\/9808","article-title":"Cost-effectiveness of ruxolitinib vs best available therapy in the treatment of myelofibrosis in Spain","volume":"5","author":"G\u00f3mez-Casares","year":"2017","journal-title":"J Health Econ Outcomes Res"},{"issue":"4","key":"10.1016\/j.jfma.2026.01.051_bib17","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1053\/j.seminhematol.2005.05.023","article-title":"Pathogenesis of thrombosis in essential thrombocythemia and polycythemia vera: the role of neutrophils","volume":"42","author":"Falanga","year":"2005","journal-title":"Semin Hematol"},{"issue":"18","key":"10.1016\/j.jfma.2026.01.051_bib18","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1182\/blood-2013-10-463646","article-title":"Thrombosis: tangled up in NETs","volume":"123","author":"Martinod","year":"2014","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.jfma.2026.01.051_bib19","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.3390\/ijms22031143","article-title":"Emerging role of neutrophils in the thrombosis of chronic myeloproliferative neoplasms","volume":"22","author":"Ferrer-Mar\u00edn","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.jfma.2026.01.051_bib21","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1182\/blood-2009-02-206797","article-title":"Perspectives on thrombosis in essential thrombocythemia and polycythemia vera: is leukocytosis a causative factor?","volume":"114","author":"Barbui","year":"2009","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.jfma.2026.01.051_bib22","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1182\/bloodadvances.2019000211","article-title":"Leukocytosis and thrombosis in essential thrombocythemia and polycythemia vera: a systematic review and meta-analysis","volume":"3","author":"Carobbio","year":"2019","journal-title":"Blood Adv"},{"issue":"1","key":"10.1016\/j.jfma.2026.01.051_bib23","doi-asserted-by":"crossref","DOI":"10.1002\/cncr.35638","article-title":"Neutrophil-to-lymphocyte ratio (NLR) at diagnosis in essential thrombocythemia: a new promising predictor of thrombotic events","volume":"131","author":"Ripamonti","year":"2025","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.jfma.2026.01.051_bib24","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41408-024-00994-z","article-title":"Neutrophil-to-lymphocyte ratio and all-cause mortality with and without myeloproliferative neoplasms-a Danish longitudinal study","volume":"14","author":"Larsen","year":"2024","journal-title":"Blood Cancer J"},{"issue":"4","key":"10.1016\/j.jfma.2026.01.051_bib25","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/ajh.27216","article-title":"Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management","volume":"99","author":"Tefferi","year":"2024","journal-title":"Am J Hematol"},{"issue":"17","key":"10.1016\/j.jfma.2026.01.051_bib26","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1056\/NEJM199504273321704","article-title":"Hydroxyurea for patients with essential thrombocythemia and a high risk of thrombosis","volume":"332","author":"Cortelazzo","year":"1995","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.jfma.2026.01.051_bib27","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.3324\/haematol.13346","article-title":"Prognostic factors for thrombosis, myelofibrosis, and leukemia in essential thrombocythemia: a study of 605 patients","volume":"93","author":"Passamonti","year":"2008","journal-title":"Haematologica"},{"issue":"6","key":"10.1016\/j.jfma.2026.01.051_bib28","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1007\/s00277-024-05754-4","article-title":"Association of JAK2V617F allele burden and clinical correlates in polycythemia vera: a systematic review and meta-analysis","volume":"103","author":"Chen","year":"2024","journal-title":"Ann Hematol"}],"container-title":["Journal of the Formosan Medical Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664626000690?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664626000690?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T08:10:41Z","timestamp":1773994241000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0929664626000690"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":27,"alternative-id":["S0929664626000690"],"URL":"https:\/\/doi.org\/10.1016\/j.jfma.2026.01.051","relation":{},"ISSN":["0929-6646"],"issn-type":[{"value":"0929-6646","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Five-year population-based study of essential thrombocythemia in Taiwan: Epidemiology, treatment patterns, and sex-based disparities","name":"articletitle","label":"Article Title"},{"value":"Journal of the Formosan Medical Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfma.2026.01.051","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2026, Formosan Medical Association. Published by Elsevier Taiwan LLC. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}